Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd
SSE:600329

Watchlist Manager
Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd Logo
Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd
SSE:600329
Watchlist
Price: 34.01 CNY -1.13% Market Closed
Market Cap: 26.2B CNY
Have any thoughts about
Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd?
Write Note

Wall Street
Price Targets

Price Targets Summary
Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd

Wall Street analysts forecast Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd is 46.72 CNY with a low forecast of 46.26 CNY and a high forecast of 48.09 CNY.

Lowest
Price Target
46.26 CNY
36% Upside
Average
Price Target
46.72 CNY
37% Upside
Highest
Price Target
48.09 CNY
41% Upside
Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd Competitors:
Price Targets
300702
Zhejiang Tianyu Pharmaceutical Co Ltd
36% Upside
605507
Guobang Pharma Ltd
19% Upside
2DT
Amneal Pharmaceuticals Inc
9% Upside
300723
Yipinhong Pharmaceutical Co Ltd
89% Upside
APPH
Apontis Pharma AG
82% Upside
GHRS
GH Research PLC
255% Upside
AVDL
Avadel Pharmaceuticals PLC
115% Upside

Revenue
Forecast

Revenue Estimate
Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd

For the last 8 years the compound annual growth rate for Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd's revenue is 2%. The projected CAGR for the next 3 years is 8%.

2%
Past Growth
8%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd

For the last 8 years the compound annual growth rate for Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd's operating income is 10%. The projected CAGR for the next 3 years is 27%.

10%
Past Growth
27%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd

For the last 8 years the compound annual growth rate for Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd's net income is 10%. The projected CAGR for the next 3 years is 18%.

10%
Past Growth
18%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd's stock price target?
Price Target
46.72 CNY

According to Wall Street analysts, the average 1-year price target for Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd is 46.72 CNY with a low forecast of 46.26 CNY and a high forecast of 48.09 CNY.

What is Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd's Revenue forecast?
Projected CAGR
8%

For the last 8 years the compound annual growth rate for Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd's revenue is 2%. The projected CAGR for the next 3 years is 8%.

What is Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd's Operating Income forecast?
Projected CAGR
27%

For the last 8 years the compound annual growth rate for Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd's operating income is 10%. The projected CAGR for the next 3 years is 27%.

What is Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd's Net Income forecast?
Projected CAGR
18%

For the last 8 years the compound annual growth rate for Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd's net income is 10%. The projected CAGR for the next 3 years is 18%.

Back to Top